Tiny pharma hits a new low with FDA refusing to review company's response to its CRL
Just before the long weekend, tiny Zosano Pharma revealed another blow to its application for approval for a migraine patch.
The FDA said the company’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
